← Back to directory

Andrew Martin

Researcher Next ID · RN-042622

Researcher · Medicine

Center for Devices and Radiological Health

Rockville, New Zealand

Accepting doctoral researchersFunding unknown
Works count
461
Citation count
15,916
H-index
61
i10-index
212

Research interests

Medicine
Prostate Cancer Treatment and Research
Radiopharmaceutical Chemistry and Applications
Prostate Cancer Diagnosis and Treatment
Cancer survivorship and care
Gastric Cancer Management and Outcomes

Publications

  • [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

    The Lancet Oncology · 2024 · 10.1016/s1470-2045(24)00135-9

  • Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    The Lancet Oncology · 2023 · 10.1016/s1470-2045(23)00529-6

  • Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

    The Lancet Oncology · 2023 · 10.1016/s1470-2045(23)00063-3

  • Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients

    New England Journal of Medicine · 2023 · 10.1056/nejmoa2203086

  • PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

    The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00605-2

  • [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00237-3

  • [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00237-3

  • Interventions commenced by early infancy to prevent childhood obesity—The EPOCH Collaboration: An individual participant data prospective meta‐analysis of four randomized controlled trials

    Pediatric Obesity · 2020 · 10.1111/ijpo.12618

  • Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

    Cancer Discovery · 2020 · 10.1158/2159-8290.cd-19-1030

  • TheraP: a randomized phase 2 trial of 177 Lu‐ PSMA ‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

    British Journal of Urology · 2019 · 10.1111/bju.14876

  • Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1903835

  • Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis

    European Respiratory Journal · 2017 · 10.1183/13993003.00157-2017

  • Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial

    Journal of Clinical Oncology · 2016 · 10.1200/jco.2015.65.1901

  • A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

    British Journal of Dermatology · 2016 · 10.1111/bjd.14662

  • A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

    New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1506197

  • Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials

    Journal of Investigative Dermatology · 2012 · 10.1038/jid.2011.459

  • Self-concept: A synergy of theory, method, and application.

    American Psychological Association eBooks · 2011 · 10.1037/13273-015

  • Safety and efficacy of pregabalin in patients with central post-stroke pain

    Pain · 2011 · 10.1016/j.pain.2010.12.023

  • Small-scale biomass CHP plants in Sweden and Finland

    Renewable and Sustainable Energy Reviews · 2011 · 10.1016/j.rser.2011.07.106

  • Treatment burden and health‐related quality of life of children with diabetes, cystic fibrosis and asthma

    Journal of Paediatrics and Child Health · 2006 · 10.1111/j.1440-1754.2006.00943.x

  • Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression

    The Journal of Clinical Psychiatry · 2005 · 10.4088/jcp.v66n1015

  • The Relationship between Asthma Severity, Family Functioning and the Health-Related Quality of Life of Children with Asthma

    Quality of Life Research · 2000 · 10.1023/a:1016655511879

  • The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL

    Quality of Life Research · 1999 · https://doi.org/10.1023/a:1026485130100

  • Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography

    Biological Psychiatry · 1997 · 10.1016/s0006-3223(97)85394-2

  • Effect of spinal surgery on lung function in Duchenne muscular dystrophy.

    Thorax · 1995 · 10.1136/thx.50.11.1173

Current projects

    No projects listed.